Zivo Bioscience Inc Stock Price, News & Analysis

Welcome to our dedicated page for Zivo Bioscience news (Ticker: ZIVO), a resource for investors and traders seeking the latest updates and insights on Zivo Bioscience stock.

ZIVO Bioscience, Inc. (ZIVO) generates news primarily through its biotech and agtech research and development activities focused on algae-derived product candidates for human and animal health. Company updates frequently highlight progress in poultry health, including studies targeting coccidiosis and Low Pathogenicity Avian Influenza (LPAI) in broiler chickens, as well as developments in human nutrition applications based on antioxidant-rich algal materials.

News items often cover results from controlled challenge and confirmatory studies conducted with academic institutions such as the University of Delaware and with major global animal health companies. These releases describe endpoints like intestinal lesion scores, feed conversion ratio, viral titers and disease transmission dynamics, and explain how ZIVO’s proprietary active ingredients perform as non-antibiotic, immune-modulating interventions in poultry production settings.

Investors and industry observers can also find announcements about collaborations, licensing discussions and funded research agreements with leading animal health companies. These stories provide insight into how ZIVO is pursuing potential exclusive licenses for its coccidiosis treatment candidate and expanding the evaluation of its immune-enhancing compounds as biologics that may complement existing vaccination strategies.

In addition, ZIVO issues communications on its human nutrition initiatives, including shareholder letters that discuss independent biochemical analyses of its algae and positioning in the nutraceutical marketplace. Corporate updates, such as participation in investor conferences and changes in financial leadership reported through SEC filings, also appear in the news flow. Bookmark this page to follow ZIVO’s latest study results, partnership developments and corporate announcements as the company advances its algae-based pipeline.